Blood Flow Restriction Therapy in Achilles Injury

🩺 Protocol Summary

Blood flow restriction (BFR) therapy is a brief and partial restriction of venous outflow of an extremity during low load resistance exercises. It is a safe and effective method of improving strength in healthy and active individuals, recovering from orthopedic pathologies and procedures. This prospective, randomized study will look at the implications this form of treatment has on the rehabilitation of Achilles injuries.

Primary Research Facility: NYU Langone Health (New York, New York)

Review these 3 basic logistical and protocol criteria extracted from the public NIH record. (This is a preliminary logistical checklist, not an official clinical eligibility determination).

Diagnosed with, undergoing evaluation for, or seeking treatment related to Achilles Injuries Tendon?

🔍 Study Population / Focus Area (Source: Protocol Primary Condition)

Aged between 18 Years and 65 Years?

🔍 Protocol Specified Age Range: 18 Years to 65 Years

Able to attend required clinic visits at NYU Langone Health (New York, New York)?

🔍 Logistical Requirement: Site at NYU Langone Health

📍 Primary Site Map

Site: NYU Langone Health — New York, New York

💰 Clinical Trial Costs & Insurance Coverage

Coverage for clinical trial participation varies depending on your health insurance policy, state legislation, and whether specific procedures are investigational research or routine medical care. Under federal law (Affordable Care Act § 2709), health insurers generally cannot drop coverage or refuse to pay for routine patient care costs incurred in approved clinical trials.

💡 Always ask the study coordinator for the trial's official Informed Consent Form, which outlines all sponsor-funded research items versus procedures billed to your insurance.